MetLife, Inc. (MET)

NYQ – Real vaqt narxi. Valyuta: USD

96.69

-0.11 (-0.11%)

Yopilishda: Aug 12, 2026, 3:59 PM EDT

95.19

-1.47 (-1.52%)

Bozordan keyin: Aug 12, 2026, 4:23 PM EDT

08.08.2026

MetLife Q2 Earnings Call Highlights

MetLife NYSE: MET reported second-quarter 2026 adjusted earnings of approximately $1.6 billion, or $2.43 per share, up 15% from a year earlier. Adjusted earnings per share increased 20%, while adjusted return on equity reached 17%, the top end of the company's 15% to 17% annual target range.

06.08.2026

MetLife's Q2 Earnings Beat Reaffirms The Buy Case As Organic Growth Stands Out

MetLife, Inc. is reaffirmed as a Buy, with quality fundamentals, strong organic growth, and a resilient dividend profile supporting continued bullish momentum. MET's diversified business model, including investment management and group benefits, drives organic growth across multiple segments despite modest profit margin expansion. The balance sheet boasts A-level credit ratings and modest leverage, but significant fixed-income exposure introduces interest rate risk, warranting ongoing monitoring.

06.08.2026

MetLife Tops Q2 Earnings Estimates on Strong Investment Income

MET tops Q2 EPS estimates as higher investment income, favorable underwriting and business volume growth lift earnings despite higher expenses.

06.08.2026

MetLife, Inc. (MET) Q2 2026 Earnings Call Transcript

06.08.2026

MetLife Pet Insurance Winner Of 2026 Pet Innovation Award For “Pet Insurance of the Year”

LOS ANGELES, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The 2026 Pet Innovation Awards today announced that MetLife Pet Insurance is the recipient of the “Pet Insurance of the Year” award. The Pet Innovation Awards is an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet care industry.

06.08.2026

Compared to Estimates, MetLife (MET) Q2 Earnings: A Look at Key Metrics

The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

05.08.2026

MetLife Announces New $3 Billion Share Repurchase Authorization

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the approximately $400 million remaining under the company's prior authorization announced in April 2025. “This new share repurchase authorization reflects our confidence in MetLife's long-term outlook and continued ability to generate capital,” said MetLife President a.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

MetLife Pet Insurance Winner Of 2026 Pet Innovation Award For “Pet Insurance of the Year”

05.08.2026

MetLife Announces New $3 Billion Share Repurchase Authorization

05.08.2026

MetLife CFO John McCallion Provides Second Quarter 2026 Financial Update Video

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a second quarter 2026 financial update video. The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world's leading financial services companie.

05.08.2026

MetLife Announces 2Q 2026 Results

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced its second quarter 2026 results. Earnings Return Per Share on Equity (ROE) 2Q 2026 2Q 2026 Net Income $1.09 ROE 11.5% Adjusted Adjusted Earnings $2.43 ROE 17.0% Net income increased 1%1 to $705 million, or $1.09 per share. Adjusted earnings increased 15% to $1.6 billion, driven by favorable underwriting and volume growth. Adjusted earnings per share increased 20% to $2.43. Premiums, fees and other revenues (PFOs) increa.

MetLife, Inc. (MET)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating